CNGT logo

Cannagistics, Inc. (CNGT) Hisse Analizi

Yalnızca bilgilendirme amaçlıdır. Finansal tavsiye değildir. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Cannagistics, Inc. (CNGT), Financial Services sektöründe faaliyet gösteriyor, son olarak $'dan işlem görüyor ve 0 piyasa değerine sahip. Büyüme potansiyeli, finansal sağlık ve momentum konusunda 44/100 (ihtiyatlı) olarak derecelendirilmiştir.

Son analiz: 16 Mar 2026
44/100 AI Puanı

Cannagistics, Inc. (CNGT) Finansal Hizmetler Profili

CEOJames W. Zimbler
Çalışanlar1
MerkezHauppauge, US
Halka Arz Yılı2006

Cannagistics, Inc., operating within the financial services sector as a shell company, focuses on developing and marketing a diverse portfolio of OTC, pharmaceutical, and nutraceutical products. Its offerings span health and wellness categories, distributed through various channels, positioning it within the competitive landscape of consumer health products.

Veri Kaynağı | Finansal Veriler Kantitatif Analiz NASDAQ Analiz: 16 Mar 2026

Yatırım Tezi

Cannagistics, Inc. presents a high-risk, high-reward investment profile given its OTC listing and limited financial information. The company's diverse product portfolio, ranging from nutraceuticals to agricultural products, offers potential revenue streams, but also introduces operational complexity. With a market capitalization of $0.00 billion and a negative P/E ratio, the company's financial performance requires careful scrutiny. The beta of 3.28 indicates high volatility compared to the market. Potential catalysts include successful product launches and expansion into new markets, but these are speculative. Investors should conduct thorough due diligence, focusing on the company's financial disclosures, revenue generation, and competitive positioning. The company's reliance on wholesale, retail, and e-commerce channels exposes it to market fluctuations and competitive pressures.

FMP finansallarına ve nicel analizine dayanmaktadır

Temel Önemli Noktalar

  • Market capitalization of $0.00 billion, indicating a micro-cap company with limited financial resources.
  • Negative P/E ratio, reflecting the company's current lack of profitability.
  • Beta of 3.28, suggesting high volatility compared to the overall market.
  • No dividend yield, indicating that the company is not currently returning capital to shareholders.
  • Operates with a single employee, highlighting the company's limited operational scale.

Rakipler & Benzerleri

Güçlü Yönler

  • Diverse product portfolio across multiple health and wellness categories.
  • Distribution network encompassing wholesale, retail, and e-commerce channels.
  • Proprietary formulations for select products.
  • Established presence in niche market segments.

Zayıflıklar

  • Limited financial resources and market capitalization.
  • Dependence on a small number of employees.
  • Lack of profitability and negative P/E ratio.
  • High beta indicating significant volatility.

Katalizörler

  • Ongoing: Expansion of product distribution through e-commerce platforms.
  • Ongoing: Development and launch of new health and wellness products.
  • Ongoing: Strategic partnerships with retail chains.
  • Upcoming: Potential for increased brand awareness through marketing initiatives.
  • Upcoming: Possible acquisitions or mergers to expand market share.

Riskler

  • Potential: Limited financial resources and market capitalization.
  • Potential: Dependence on a small number of employees.
  • Ongoing: Intense competition from larger, more established companies.
  • Ongoing: Evolving consumer preferences and market trends.
  • Potential: Regulatory scrutiny and compliance requirements.

Büyüme Fırsatları

  • Growth opportunity 1: Expansion of e-commerce presence: Cannagistics can capitalize on the growing e-commerce market by enhancing its online sales channels. The global e-commerce market is projected to reach trillions of dollars by 2026. By investing in its online platform, improving its digital marketing strategies, and offering competitive pricing, Cannagistics can attract a wider customer base and increase its sales volume. This strategy requires investment in technology and logistics, but offers the potential for significant revenue growth.
  • Growth opportunity 2: Strategic partnerships with retail chains: Cannagistics can pursue partnerships with major retail chains to increase its product distribution. Securing shelf space in established retail stores would provide access to a larger customer base and enhance brand visibility. This strategy requires negotiating favorable terms with retailers and ensuring consistent product supply. The timeline for establishing such partnerships could range from several months to a year, depending on the negotiation process and retailer requirements.
  • Growth opportunity 3: Development of innovative products: Cannagistics can invest in research and development to create new and innovative products that address unmet consumer needs. Focusing on emerging trends in health and wellness, such as personalized nutrition and natural remedies, could provide a competitive edge. The timeline for developing and launching new products can vary depending on the complexity of the product and regulatory requirements, but typically ranges from one to three years.
  • Growth opportunity 4: Geographic expansion into new markets: Cannagistics can expand its operations into new geographic markets, both domestically and internationally. Identifying regions with strong demand for its products and establishing distribution networks in those areas could drive revenue growth. This strategy requires careful market research and adaptation of products to local preferences. The timeline for geographic expansion can vary depending on the target market and regulatory requirements, but typically ranges from one to two years.
  • Growth opportunity 5: Leveraging veterinary and agricultural products: Cannagistics can further develop and market its products for veterinary and agricultural use. The market for animal health and agricultural products is substantial, offering opportunities for diversification and revenue growth. By focusing on innovative solutions for animal care and crop enhancement, Cannagistics can tap into these growing markets. The timeline for developing and marketing these products can vary depending on regulatory requirements and market acceptance, but typically ranges from one to two years.

Fırsatlar

  • Expansion of e-commerce presence to reach a wider customer base.
  • Strategic partnerships with retail chains to increase product distribution.
  • Development of innovative products to address unmet consumer needs.
  • Geographic expansion into new markets, both domestically and internationally.

Tehditler

  • Intense competition from larger, more established companies.
  • Evolving consumer preferences and market trends.
  • Regulatory scrutiny and compliance requirements.
  • Economic downturns affecting consumer spending.

Rekabet Avantajları

  • Diverse product portfolio spanning multiple health and wellness categories.
  • Proprietary formulations for certain products, such as Canagel.
  • Distribution network encompassing wholesale, retail, and e-commerce channels.
  • Established brand presence in select market segments.

CNGT Hakkında

Cannagistics, Inc., formerly known as Precious Investments, Inc., underwent a name change in May 2019, marking a shift in its business focus. Incorporated in 2004 and based in Hauppauge, New York, the company develops, markets, and sells a range of over-the-counter (OTC), pharmaceutical, nutraceutical, cosmetic, and health and wellness products. Its product portfolio includes Canagel, an anhydrous hydrogel composition and delivery system; Silverpro, a compression fabric; KidzStrips, a thin film children's toothpaste strip; and ImmuniZin, an immune booster, as well as HydroSoil, a novel fertilizer. Cannagistics also offers IcyEase, an ice pack for muscle/joint pain; Slim-D, an appetite-suppressant oral strip; Energy Lighting Strips for oral energy; Micro Voltage Trans Derm C for pain; and CBD 600, a hemp rich oral tincture. These products target various consumer needs, including pain relief, anti-aging, hygiene, energy, and immune system and biochemical support, as well as skin creams for treatment of disorders and rejuvenations. The company also provides products for veterinary and agricultural use, expanding its reach beyond human consumers. Cannagistics distributes its products through a mix of wholesale and retail channels, including brick and mortar stores and e-commerce platforms, aiming to reach a broad customer base.

Ne Yaparlar

  • Develops over-the-counter (OTC) products.
  • Markets pharmaceutical products.
  • Sells nutraceutical products.
  • Offers cosmetic products.
  • Provides health and wellness products.
  • Distributes products through wholesale channels.
  • Sells products through retail establishments.
  • Utilizes e-commerce platforms for sales.

İş Modeli

  • Develops and manufactures a range of health and wellness products.
  • Sells products through wholesale distribution to retailers.
  • Markets products directly to consumers through e-commerce platforms.
  • Generates revenue through product sales.

Sektör Bağlamı

Cannagistics, Inc. operates within the shell companies industry, a segment of the financial services sector characterized by companies with limited operations and often speculative ventures. The market for OTC, pharmaceutical, nutraceutical, and cosmetic products is highly competitive, with established players and evolving consumer preferences. Cannagistics' success depends on its ability to differentiate its products, establish effective distribution channels, and manage its operations efficiently. The company faces competition from larger, more established companies with greater resources and brand recognition. The industry is also subject to regulatory scrutiny and evolving consumer trends, requiring companies to adapt and innovate to maintain their market position.

Kilit Müşteriler

  • Retail consumers seeking health and wellness products.
  • Wholesale distributors and retailers.
  • Veterinary and agricultural customers.
  • Online shoppers.
AI Güveni: 79% Güncellendi: 16 Mar 2026

Finansallar

Grafik & Bilgi

Cannagistics, Inc. (CNGT) hisse senedi fiyatı: Price data unavailable

Son Haberler

CNGT için son haber bulunmamaktadır.

Analist Konsensüsü

Fikir Birliği Derecelendirmesi

CNGT için Benzinga, Yahoo Finance ve Finnhub'dan toplanan Al/Tut/Sat önerileri.

Fiyat Hedefleri

CNGT için Wall Street fiyat hedefi analizi.

MoonshotScore

44/100

Bu puan ne anlama geliyor?

MoonshotScore, CNGT'ın büyüme potansiyelini inovasyon, pazar yıkımı, finansal sağlık ve momentum dahil olmak üzere birden fazla faktörde 0-100 ölçeğinde derecelendirir.

Sınıflandırma

Sektör Shell Companies

Yönetim: James W. Zimbler

Managing

James W. Zimbler serves as the managing executive of Cannagistics, Inc. Information regarding Mr. Zimbler's detailed career history, educational background, and previous roles is not available in the provided data. His leadership is central to the company's strategic direction and operational execution. As managing executive, he oversees all aspects of the company's business, from product development and marketing to sales and distribution.

Sicil: Due to limited information, James W. Zimbler's specific achievements and strategic decisions at Cannagistics, Inc. cannot be fully assessed. The company's performance and milestones under his leadership require further evaluation based on available financial and operational data. His tenure is marked by the company's focus on developing and marketing a diverse range of health and wellness products.

CNGT OTC Piyasa Bilgileri

The OTC Other tier represents the lowest tier of the OTC market, indicating that Cannagistics, Inc. may not meet the minimum financial standards or disclosure requirements for higher tiers like OTCQX or OTCQB. Companies in this tier often have limited trading volume and may not be subject to the same level of regulatory oversight as exchange-listed companies. Investing in OTC Other stocks carries significant risks due to the potential for limited information and higher volatility. These stocks are typically more speculative and require a higher degree of due diligence.

  • OTC Katmanı: OTC Other
  • Açıklama Durumu: Unknown
Likidite: Given that Cannagistics, Inc. trades on the OTC Other tier, liquidity is likely limited. This can result in wide bid-ask spreads, making it difficult to buy or sell shares at desired prices. Low trading volume can also lead to price volatility and potential difficulties in executing large trades. Investors should be prepared for potential delays and price fluctuations when trading CNGT shares.
OTC Risk Faktörleri:
  • Limited financial disclosure and transparency.
  • Potential for low trading volume and liquidity.
  • Higher price volatility compared to exchange-listed stocks.
  • Increased risk of fraud or manipulation.
  • Limited regulatory oversight and investor protection.
Durum Tespiti Kontrol Listesi:
  • Verify the company's financial statements and SEC filings (if available).
  • Research the background and experience of the company's management team.
  • Assess the company's business model and competitive landscape.
  • Evaluate the company's revenue generation and profitability.
  • Review the company's legal and regulatory compliance.
  • Monitor trading volume and price volatility.
  • Consult with a qualified financial advisor.
Meşruiyet Sinyalleri:
  • Company's incorporation date (2004) suggests some operating history.
  • Presence of a physical headquarters in Hauppauge, New York.
  • Development and marketing of a range of health and wellness products.
  • Active website and online presence (if available).
  • Independent third-party verification of product claims (if available).

CNGT Hakkında Sıkça Sorulan Sorular

CNGT için değerlendirilmesi gereken temel faktörler nelerdir?

Cannagistics, Inc. (CNGT) şu anda yapay zeka skoru 44/100, düşük puanı gösteriyor. Temel güçlü yan: Diverse product portfolio across multiple health and wellness categories.. İzlenmesi gereken birincil risk: Potential: Limited financial resources and market capitalization.. Bu bir finansal tavsiye değildir.

CNGT MoonshotScore'u nedir?

CNGT şu anda MoonshotScore'da 44/100 (Derece D) alıyor, bu da düşük derecelendirme gösteriyor. Puan, 9 kantitatif KPI genelinde büyüme potansiyelini, finansal sağlığı, piyasa momentumunu ve risk faktörlerini değerlendirir. En son piyasa verileri kullanılarak günlük olarak yeniden hesaplanır. Bu puan yalnızca bilgilendirme amaçlıdır.

CNGT verileri ne sıklıkla güncellenir?

CNGT fiyatları ABD piyasa saatleri (hafta içi 9:30-16:00 ET) sırasında gerçek zamanlı olarak güncellenir. Temeller, üç aylık veya yıllık beyanlardan sonra yenilenir. Analist derecelendirmeleri ve yapay zeka öngörüleri günlük olarak güncellenir. Haberler, finans kaynaklarından sürekli olarak toplanır.

Analistler CNGT hakkında ne diyor?

CNGT için analist kapsamı, büyük araştırma şirketlerinden fikir birliği derecelendirmelerini (al, tut, sat), 12 aylık fiyat hedeflerini ve kazanç tahminlerini içerir. Temel veri noktaları: fikir birliği hedef fiyatı, kapsayan analist sayısı, son yükseltmeler veya düşürmeler ve kazanç beklentilerini aşma/aşamama geçmişi. Bu sayfadaki Analist Konsensüsü bölümüne bakın.

CNGT'a yatırım yapmanın riskleri nelerdir?

CNGT için risk kategorileri arasında piyasa riski, şirkete özgü risk (yönetim, rekabet), finansal risk (borç, nakit yakımı) ve makroekonomik risk (oranlar, enflasyon) yer alır. Yapay zeka analizi tarafından belirlenen önemli bir risk: Potential: Limited financial resources and market capitalization.. 1,0'ın üzerindeki beta, S&P 500'den daha yüksek volatiliteyi gösterir. Ayrıntılar için bu sayfadaki Risk Faktörleri bölümünü inceleyin. Tüm yatırımlar kayıp riski taşır.

CNGT'ın P/E oranı nedir?

CNGT için P/E (fiyat-kazanç) oranı, mevcut hisse senedi fiyatını hisse başına kazancıyla karşılaştırır. Daha yüksek bir P/E büyüme beklentilerini gösterebilirken, daha düşük bir P/E değer veya azalan kazançlar gösterebilir. Anlamlı bir bağlam için CNGT'ın P/E'sini sektördeki emsalleriyle ve S&P 500 ortalamasıyla karşılaştırın. Mevcut değerleme metrikleri için Finansallar sekmesini kontrol edin.

CNGT aşırı değerli mi, yoksa düşük değerli mi?

Cannagistics, Inc. (CNGT)'ın aşırı değerli mi yoksa düşük değerli mi olduğunu belirlemek, birden fazla metriği incelemeyi gerektirir. Kapsamlı bir görünüm için değerleme oranlarını (P/E, P/S, EV/EBITDA) sektördeki emsallerle karşılaştırın. Bu bir finansal tavsiye değildir.

CNGT'ın temettü verimi nedir?

Cannagistics, Inc. (CNGT) şu anda düzenli bir temettü ödemiyor veya temettü verimi verileri mevcut değil. Büyüme odaklı şirketler genellikle temettü ödemek yerine karları yeniden yatırır. En son temettü bilgileri ve ödeme geçmişi için Finansallar sekmesini kontrol edin.

Sorumluluk reddi: Bu içerik yalnızca bilgilendirme amaçlıdır ve yatırım tavsiyesi teşkil etmez. Her zaman kendi araştırmanızı yapın ve bir finans uzmanına danışın.

Resmi Kaynaklar

Analiz güncellendi AI Puanı günlük olarak yenilenir
Veri Kaynakları ve Metodoloji
Piyasa verileri Financial Modeling Prep ve Yahoo Finance tarafından sağlanmaktadır. AI analizi Stock Expert AI tescilli algoritmaları ile yapılmaktadır. Teknik göstergeler endüstri standardı hesaplamalarla üretilmektedir. Son güncelleme: .

Veriler yalnızca bilgilendirme amaçlı sağlanmıştır.

Analiz Notları
  • Limited financial information available for Cannagistics, Inc.
  • OTC stocks are inherently more risky than exchange-listed stocks.
  • AI analysis pending for CNGT.
Veri Kaynakları

Popüler Hisseler